aTyr Pharma, Inc. (ATYR)

NASDAQ

$0.17

$--

(0.00%)

Pre-Market

aTyr Pharma, Inc. (ATYR) Live Price Chart

Last updated: ⁦2026-10-22 11:17:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

aTyr Pharma, Inc. (ATYR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.17, with a market capitalization of $17.00M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.17 to $1.11. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$17.00M
Open	$0.17
Day's High	$7.29
Day's Low	$0.17
Previous Close	$0.17
Volume	918.00
Average Volume	3.32M
P/E Ratio	--
52-Week High	$1.11
52-Week Low	$0.17
Dividend Yield	--
Earnings Date	--

aTyr Pharma, Inc. (ATYR) Pre-Market Stock Price

aTyr Pharma, Inc. (ATYR) is trading at $0.17 in pre-market trading as of 2026-10-22 11:12:00, down 0.17% ($0.00) from the previous close of $0.17

Pre-market trading shows how investors are pricing ATYR before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

aTyr Pharma, Inc. (ATYR) 7-Day Stock Price Change

Over the past seven days, aTyr Pharma, Inc. (ATYR) moved from $0.20 to $0.17, representing a decline of 14.47% ($0.03).

The stock traded between $0.17 and $0.22 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.99 million shares, up versus the previous seven-day period, indicating higher trading activity.

ATYR 52-Week Price Position

Position in Range: 0.7%

52W Low$0.17

52W High$1.11

ATYR is currently trading at $0.17, placing it 0.7% of the way from its 52-week low of $0.17 to its 52-week high of $1.11. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is aTyr Pharma, Inc. (ATYR)?

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

aTyr Pharma, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	58
Exchange	NASDAQ
Company Website	https://www.atyrpharma.com

How to Buy aTyr Pharma, Inc. (ATYR) Stock on MEXC

Eligible investors can buy real shares of aTyr Pharma, Inc. (ATYR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ATYR and Place Your Order

Open the RealStocks trading page and search for ATYR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is aTyr Pharma, Inc. (ATYR) stock price today?

aTyr Pharma, Inc. (ATYR) is currently trading at $ 0.17, down 0.17% ($0.00) from the previous close of $ 0.17. Intraday prices update in real time during regular trading hours.

2.Is ATYR stock going up or down today?

As of 2026-10-22 11:12:00, ATYR is trading at $ 0.17, down 0.17% ($0.00) from its previous close of $ 0.17. The stock has traded between $ 0.17 and $ 7.29 during today’s regular session. Past price movements do not guarantee future results.

3.What is ATYR pre-market price?

As of 2026-10-22 11:12:00, ATYR is trading at $ 0.17 in pre-market trading, down 0.17% ($0.00) from the previous close of $ 0.17. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ATYR after-hours price?

As of 2026-10-22 11:12:00, ATYR is trading at $ 0.17 in after-hours trading, down 0.17% ($0.00) from the regular-session close of $ 0.17. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ATYR stock trading now?

ATYR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ATYR sit relative to its 52-week high and low?

Over the past 52 weeks, ATYR has traded between a low of $ 0.17 and a high of $ 1.11. At $ 0.17, the stock is positioned 0.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is aTyr Pharma, Inc. in?

aTyr Pharma, Inc. (ATYR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is aTyr Pharma, Inc.'s market capitalization and where is it listed?

aTyr Pharma, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 17.00M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ATYR valued in terms of P/E ratio and EPS?

ATYR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.62. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does aTyr Pharma, Inc. pay a dividend?

aTyr Pharma, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.